Closing Soon
Procedure and Device for Pulmonary Parenchymal Lesions, sponsored by Middlemore Hospital, New Zealand
Get in touch This trial recruits from January 2015 for 152 weeks
Samantha Herath
Phone: +64211298979
Email: scherath@yahoo.com
Inclusion Criteria
Age: From 18 Years To 90 Years
Gender: Both
Inclusion Criteria
Patient referred for R-EBUS as per routine management.
Patient judged to be medically stable to give consent for this study.
Exclusion Criteria
-Unsuitable for flexible bronchoscopy and biopsyINR>1.5
Platelets<150.
Hb> 80g/l
Liver function tests (AST/ALT) <2 times upper limit of normal
Neutrophil count >1.0
EGFR >30ml/kg/min
On anticoagulation, that cannot be withheld for the procedure, due to medical reasons (e.g. On-clopidogrel with recent drug-eluting stent placement.)
Exclusion Criteria
NCT02739126
Comparing the Diagnostic Yield of Radial Endo-Bronchial Ultra-Sound Guided Biopsy When Using a Thick (1.7mm) With an Aspiration Needle Biopsy Vs. a Thin USS Probe (1.4mm), in Peripheral Lung Lesions.
Comparing the Diagnostic Yield of Radial EBUS Guided Biopsies When Using a Thick (1.7mm) Vs. Thin (1.4 mm) USS Probe.